104 related articles for article (PubMed ID: 34906623)
21. Enhancer of Zeste homolog 2 (EZH2) induces epithelial-mesenchymal transition in endometriosis.
Zhang Q; Dong P; Liu X; Sakuragi N; Guo SW
Sci Rep; 2017 Jul; 7(1):6804. PubMed ID: 28754964
[TBL] [Abstract][Full Text] [Related]
22. EZH2 promotes angiogenesis through inhibition of miR-1/Endothelin-1 axis in nasopharyngeal carcinoma.
Lu J; Zhao FP; Peng Z; Zhang MW; Lin SX; Liang BJ; Zhang B; Liu X; Wang L; Li G; Tian WD; Peng Y; He ML; Li XP
Oncotarget; 2014 Nov; 5(22):11319-32. PubMed ID: 25237831
[TBL] [Abstract][Full Text] [Related]
23. Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis.
Au SL; Wong CC; Lee JM; Fan DN; Tsang FH; Ng IO; Wong CM
Hepatology; 2012 Aug; 56(2):622-31. PubMed ID: 22370893
[TBL] [Abstract][Full Text] [Related]
24. Vimentin is a crucial target for anti-metastasis therapy of nasopharyngeal carcinoma.
Wang W; Yi M; Zhang R; Li J; Chen S; Cai J; Zeng Z; Li X; Xiong W; Wang L; Li G; Xiang B
Mol Cell Biochem; 2018 Jan; 438(1-2):47-57. PubMed ID: 28744809
[TBL] [Abstract][Full Text] [Related]
25. Capn4 is a marker of poor clinical outcomes and promotes nasopharyngeal carcinoma metastasis via nuclear factor-κB-induced matrix metalloproteinase 2 expression.
Zheng PC; Chen X; Zhu HW; Zheng W; Mao LH; Lin C; Liu JN; Zheng M
Cancer Sci; 2014 Jun; 105(6):630-8. PubMed ID: 24703594
[TBL] [Abstract][Full Text] [Related]
26. LncRNA MALAT1 promotes epithelial-to-mesenchymal transition of esophageal cancer through Ezh2-Notch1 signaling pathway.
Chen M; Xia Z; Chen C; Hu W; Yuan Y
Anticancer Drugs; 2018 Sep; 29(8):767-773. PubMed ID: 29916899
[TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA AWPPH enhances malignant phenotypes in nasopharyngeal carcinoma via silencing PTEN through interacting with LSD1 and EZH2.
Guo D; Liu F; Zhang L; Bian N; Liu L; Kong L; Hu Q; Wang Z
Biochem Cell Biol; 2021 Apr; 99(2):195-202. PubMed ID: 32663416
[TBL] [Abstract][Full Text] [Related]
28. Oxidored-nitro domain containing protein 1 (NOR1) expression suppresses slug/vimentin but not snail in nasopharyngeal carcinoma: Inhibition of EMT in vitro and in vivo in mice.
Wang W; Li X; Zhang W; Li W; Yi M; Yang J; Zeng Z; Colvin Wanshura LE; McCarthy JB; Fan S; Zheng P; Chen S; Xiang B; Li G
Cancer Lett; 2014 Jun; 348(1-2):109-18. PubMed ID: 24657653
[TBL] [Abstract][Full Text] [Related]
29. [Effects of enhancer of zeste homolog (EZH2) downregulation on the proliferation and invasion of nasopharyngeal carcinoma cell and the possible mechanisms].
LIANG BJ; LI XP; LU J; LIN SX; LIU X; LI G; ZHANG B; WANG L; LUO HN; WAN RQ; TIAN WD
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Apr; 47(4):298-304. PubMed ID: 22800347
[TBL] [Abstract][Full Text] [Related]
30. Let-7a inhibits proliferation and induces apoptosis by targeting EZH2 in nasopharyngeal carcinoma cells.
Cai K; Wan Y; Sun G; Shi L; Bao X; Wang Z
Oncol Rep; 2012 Dec; 28(6):2101-6. PubMed ID: 22972404
[TBL] [Abstract][Full Text] [Related]
31. Eudesmin exerts antitumor effects by down-regulating EZH2 expression in nasopharyngeal carcinoma cells.
Yu M; Li Y; Li M; Lu D
Chem Biol Interact; 2019 Jul; 307():51-57. PubMed ID: 31026422
[TBL] [Abstract][Full Text] [Related]
32. Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101, and miR-98.
Alajez NM; Shi W; Hui AB; Bruce J; Lenarduzzi M; Ito E; Yue S; O'Sullivan B; Liu FF
Cell Death Dis; 2010 Oct; 1(10):e85. PubMed ID: 21368858
[TBL] [Abstract][Full Text] [Related]
33. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429.
Sui CJ; Zhou YM; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM
J Mol Med (Berl); 2016 Nov; 94(11):1281-1296. PubMed ID: 27380494
[TBL] [Abstract][Full Text] [Related]
34. Resveratrol Suppresses Human Nasopharyngeal Carcinoma Cell Growth Via Inhibiting Differentiation Antagonizing Non-Protein Coding RNA (DANCR) Expression.
Zhang J; Jin X; Zhou C; Zhao H; He P; Hao Y; Dong Q
Med Sci Monit; 2020 Jul; 26():e923622. PubMed ID: 32683392
[TBL] [Abstract][Full Text] [Related]
35. Aberrant DNA methylation and tumor suppressive activity of the EBF3 gene in gastric carcinoma.
Kim J; Min SY; Lee HE; Kim WH
Int J Cancer; 2012 Feb; 130(4):817-26. PubMed ID: 21387304
[TBL] [Abstract][Full Text] [Related]
36. Blocking PI3K/Akt signaling attenuates metastasis of nasopharyngeal carcinoma cells through induction of mesenchymal-epithelial reverting transition.
Jiang H; Gao M; Shen Z; Luo B; Li R; Jiang X; Ding R; Ha Y; Wang Z; Jie W
Oncol Rep; 2014 Aug; 32(2):559-66. PubMed ID: 24889918
[TBL] [Abstract][Full Text] [Related]
37. [Expressions of p53 pathway genes and EZH2 in undifferentiated nasopharyngeal carcinoma].
Liu XD; Ji MF
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jun; 31(6):1029-33. PubMed ID: 21690062
[TBL] [Abstract][Full Text] [Related]
38. Targeting of EZH2 inhibits epithelial‑mesenchymal transition in head and neck squamous cell carcinoma via regulating the STAT3/VEGFR2 axis.
Zhao M; Hu X; Xu Y; Wu C; Chen J; Ren Y; Kong L; Sun S; Zhang L; Jin R; Zhou X
Int J Oncol; 2019 Nov; 55(5):1165-1175. PubMed ID: 31545422
[TBL] [Abstract][Full Text] [Related]
39. Alterations in enhancer of zeste homolog 2, matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression are associated with ex vivo and in vitro bone metastasis in renal cell carcinoma.
Wang J; Ren Y; Guo X; Cheng H; Ye Y; Qi J; Yang C; You H
Mol Med Rep; 2015 May; 11(5):3585-92. PubMed ID: 25571919
[TBL] [Abstract][Full Text] [Related]
40. Aberrant expression of nuclear vimentin and related epithelial-mesenchymal transition markers in nasopharyngeal carcinoma.
Luo W; Fang W; Li S; Yao K
Int J Cancer; 2012 Oct; 131(8):1863-73. PubMed ID: 22307379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
